Clinical Trials Directory

Trials / Conditions / Oropharyngeal Cancer

Oropharyngeal Cancer

95 registered clinical trials studyying Oropharyngeal Cancer18 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingA Single Arm Phase II Trial in p16-positive Oropharynx Cancer of Selective Dose De-escalation of nodAl VolumEs
NCT07418034
University of Maryland, BaltimorePhase 2
RecruitingNeoadjuvant Chemotherapy and Programmed Cell Death Protein 1(PD-1) Inhibition for Head and Neck Cancer Treatme
NCT07209189
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 2
Not Yet RecruitingSurgery With or Without Neoadjuvant Treatment of SBRT Plus Chemoimmunotherapy in Resectable Locally Advanced O
NCT07402538
Sun Yat-sen UniversityPhase 3
RecruitingToripalimab in Combination With Standard Treatment for Human Papillomavirus (HPV) Positive Throat Cancer
NCT07290621
University of ChicagoPhase 2
RecruitingUsing CircuLating Tumor DNA to Risk Adapt Post-Operative Therapy for HPV-associated Oropharyngeal Cancer
NCT06445114
Zachary ZumstegPhase 2
RecruitingPIRATES: Image-guided Hyper-fractioned Dose-escalation With Proton Therapy for Head and Neck Cancer
NCT06446713
University Medical Center GroningenPhase 1
RecruitingIntratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery
NCT06747390
Ryan CareyPhase 1
Not Yet RecruitingAutologous T Cells Targeting HPV16 HPV18 & Survivin in Patients With R/R HPV-related Oropharyngeal Cancers
NCT05582590
NexImmune Inc.Phase 1
RecruitingBiomarker Approach to Screening for the Early Detection of HPV-related Oropharyngeal Cancer (BASH OPC)
NCT06305676
H. Lee Moffitt Cancer Center and Research Institute
UnknownStandard Pulsed Radiofrequency Versus Supervoltage Pulsed Radiofrequency Glossopharyngeal Nerve in Oropharynge
NCT06121102
National Cancer Institute, EgyptN/A
Active Not RecruitingBALSTILIMAB on Viral Clearance in HPV+ Oropharyngeal Cancer Patients
NCT05363709
M.D. Anderson Cancer CenterPhase 2
RecruitingLiposomal Bupivacaine and Transoral Robotic Surgery
NCT05862792
Geisinger Clinic
RecruitingA Phase II Study for p16+ Oropharyngeal Cancer PerSonalized De-escalation Treatment at University of MIchigan
NCT05894083
University of Michigan Rogel Cancer CenterPhase 2
Active Not RecruitingA Study Using Human Papillomavirus (HPV) DNA Testing to Detect HPV-Related Oropharyngeal Cancer (OPC)
NCT05814549
Memorial Sloan Kettering Cancer Center
UnknownHRYZ-T101 TCR-T Cell for HPV-18 Positive Advanced Solid Tumor
NCT05787535
HRYZ Biotech Co.Phase 1
RecruitingSPECT-CT Guided ELEctive Contralateral Neck Treatment for Patients With Lateralized Oropharyngeal Cancer
NCT05451004
Canadian Cancer Trials GroupPhase 3
RecruitingA Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Canc
NCT05491512
Memorial Sloan Kettering Cancer CenterPhase 2
RecruitingLymphatic Mapping Of Oropharyngeal Cancer
NCT04498221
University College, LondonN/A
UnknownPD-1 Inhibitor Based Induction Chemotherapy Followed by De-escalation Protocols in OPSCC
NCT06156891
Fudan UniversityPhase 2
RecruitingRole of Liquid Biopsies in HPV-associated Cancer Treatment Monitoring
NCT05774561
The Institute of Molecular and Translational Medicine, Czech Republic
RecruitingImmune Biomarker Study for Head and Neck Cancer
NCT05375266
University of Erlangen-Nürnberg Medical School
Active Not RecruitingA Phase I/II Study of Combination Immunotherapy for Advanced Cancers Including HPV-Associated Malignancies, Sm
NCT04708470
National Cancer Institute (NCI)Phase 1 / Phase 2
CompletedProspective Study for the Prognostic and Predictive Role of Circulating Tumor Cells in Patients With Oropharyn
NCT04696744
Hospices Civils de Lyon
CompletedEvaluation of the Photobiomodulation Using LED Lamp for Curative Treatment of Radio-induced Mucositis.
NCT04251949
Centre Oscar LambretPhase 2
Active Not RecruitingEnhancing Self Care Among Oral Cancer Survivors: The Empowered Survival Trial
NCT04713449
Rutgers, The State University of New JerseyN/A
CompletedHYHOPE: De-intensified Hypofractionated Radiation Therapy for HPV-associated Oropharynx Cancer
NCT04580446
University of Texas Southwestern Medical CenterPhase 1
CompletedPostoperative Pain, Why Still in Hospital and DAOH Following TORS for SCCUP & OSAS
NCT04189107
Rigshospitalet, DenmarkPhase 3
Active Not RecruitingHPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associ
NCT04432597
National Cancer Institute (NCI)Phase 1 / Phase 2
UnknownPrevalence of Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS) Following Squamous Cell Carcinomas of the Orop
NCT04440618
Poitiers University Hospital
Active Not RecruitingCombination Immunotherapy in Subjects With Advanced HPV Associated Malignancies
NCT04287868
National Cancer Institute (NCI)Phase 1 / Phase 2
RecruitingAssessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiot
NCT04019548
Jules Bordet InstitutePhase 3
UnknownPEARL PET-based Adaptive Radiotherapy Clinical Trial
NCT03935672
Velindre NHS TrustN/A
Active Not RecruitingDe-Escalation Radiotherapy in Patients With Low-Risk HPV-Related Oropharyngeal Squamous Cell Carcinoma
NCT03822897
Canadian Cancer Trials GroupPhase 2
CompletedMolecular Signatures of HPV+ ORL Cancers (OROPAP)
NCT04189003
Assistance Publique - Hôpitaux de Paris
TerminatedTraceIT Tissue Marker to Mark the Primary Resection Bed Margins of Oropharyngeal Cancers
NCT03713021
Washington University School of MedicineN/A
CompletedFunctional Results of Soft Palate Free Flap Reconstruction
NCT03890783
Hospices Civils de Lyon
Active Not RecruitingEValuating the Safety Of De-escaLated Head and Neck Irradiation in HPV positivE Oropharynx Cancer in Non-smoke
NCT03777384
Sanford Health
Active Not RecruitingTORS De-Intensification Protocol Version 2.0: Dose and Volume Reduction in the Neck
NCT03729518
Abramson Cancer Center at Penn MedicineN/A
CompletedUse of a Proliferation Saturation Index to Determine Personalized Radiotherapy for HPV + Oropharyngeal Cancers
NCT03656133
H. Lee Moffitt Cancer Center and Research InstituteN/A
CompletedIntegrating a Health Information Technology System for Primary and Secondary Cervical Cancer Prevention
NCT03346915
Boston Medical CenterN/A
TerminatedCytID Analysis of Oral Lesions
NCT03555721
The University of Texas Health Science Center, Houston
TerminatedUtomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal Cancer
NCT03258008
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingChemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer
NCT03383094
Loren Mell, MDPhase 2
CompletedM7824 in Subjects With HPV Associated Malignancies
NCT03427411
National Cancer Institute (NCI)Phase 2
Active Not RecruitingPrimary Radiotherapy Versus Primary Surgery for HPV-Associated Oropharyngeal Cancer
NCT03210103
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sN/A
WithdrawnPROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved Swallowing
NCT03423264
University of ChicagoPhase 2
Active Not RecruitingTrial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Orop
NCT03224000
M.D. Anderson Cancer CenterPhase 2
UnknownEvaluation of HPV OncoTect ™ for the Etiological Diagnosis of HPV-induced Oropharyngeal Cancers
NCT03604588
Gustave Roussy, Cancer Campus, Grand ParisN/A
UnknownComparative Effectiveness Trial of Transoral Head and Neck Surgery Followed by Adjuvant Radio(Chemo)Therapy Ve
NCT03691441
Universitätsklinikum Hamburg-EppendorfPhase 4
CompletedFiclatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell
NCT03422536
University of ArizonaPhase 2
Active Not RecruitingStudy Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma
NCT02984410
European Organisation for Research and Treatment of Cancer - EORTCN/A
CompletedSpeech-based AI-driven Diagnostics and Rehabilitation for Oral and Oropharyngeal Cancer.
NCT07347899
Yudong Xiao
CompletedProspective, Multicenter da Vinci® SP™ Surgical System TORS Study
NCT03049280
Intuitive SurgicalN/A
Active Not RecruitingMen and Women Offering Understanding of Throat HPV
NCT03644563
Johns Hopkins University
UnknownuPAR PET/CT for Staging Advanced and Localised Oral and Oropharyngeal Cancer
NCT02960724
Rigshospitalet, DenmarkPhase 2
CompletedImpact of HPV Vaccine On The Prevalence Of HPV In Norway
NCT02934724
Oslo University Hospital
WithdrawnCetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma
NCT02298595
Julie E. Bauman, MD, MPHPhase 1 / Phase 2
CompletedUsefulness of Integrated PET/MRI in Oropharyngeal Squamous Cell Carcinoma Evaluation
NCT05299957
Chang Gung Memorial Hospital
Active Not RecruitingCompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC)
NCT04116047
University of BirminghamPhase 3
CompletedEstablishing Lymphedema and Fibrosis Measures in Oral Cancer Patients
NCT02412241
Vanderbilt-Ingram Cancer CenterN/A
CompletedImproving Trans-oral Surgical Outcomes Through Intra-operative Image Guidance
NCT02405000
Dartmouth-Hitchcock Medical CenterN/A
CompletedExosome Testing as a Screening Modality for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinom
NCT02147418
New Mexico Cancer Research Alliance
CompletedHPV Vaccination: Evaluation of Reminder Prompts for Doses 2 & 3
NCT02558803
Regenstrief Institute, Inc.N/A
CompletedT Cell Receptor Immunotherapy Targeting HPV-16 E6 for HPV-Associated Cancers
NCT02280811
National Cancer Institute (NCI)Phase 1 / Phase 2
TerminatedRobotic Surgery for Oropharyngeal Squamous Cell Carcinoma
NCT02225496
M.D. Anderson Cancer CenterPhase 2
CompletedA Pilot Study at a Single-Institution of Pregabalin in the Management of Mucositis Pain in Patients Undergoing
NCT02277548
Abramson Cancer Center at Penn MedicineN/A
CompletedHPV Vaccination: An Investigation of Physician Reminders and Recommendation Scripts
NCT02551887
Regenstrief Institute, Inc.N/A
CompletedA Single-arm Phase II Study of Post-Transoral Robotic Surgery (TORS) Alone to the Primary Tumor Site and Selec
NCT02159703
Abramson Cancer Center at Penn MedicinePhase 2
RecruitingIntegrated Cancer Repository for Cancer Research
NCT02012699
University of Nebraska
WithdrawnModified Barium Swallow in Measuring Swallowing Function After Surgery in Patients With Oropharyngeal Cancer
NCT01767961
Wake Forest University Health SciencesN/A
UnknownObstructive Sleep Apnea Syndrome After Oropharyngeal Cancer Treatment
NCT02881723
Assistance Publique Hopitaux De MarseilleN/A
Completed18F-FDG-PET Guided Dose-Painting With Intensity Modulated Radiotherapy in Oropharyngeal Tumours
NCT02953197
Guy's and St Thomas' NHS Foundation TrustPhase 1
CompletedTrismus Trial of Therabite vs Wooden Spatula in Head and Neck Cancer Patients
NCT01733797
Brynn ChappellPhase 2
TerminatedAcupuncture in Reducing the Severity of Chemoradiation-induced Mucositis in Patients With Oropharyngeal Cancer
NCT01883908
University of Maryland, BaltimoreN/A
WithdrawnReflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy
NCT00928161
M.D. Anderson Cancer CenterN/A
WithdrawnComplete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema
NCT00951470
M.D. Anderson Cancer CenterN/A
CompletedValproic Acid and Platinum-based Chemoradiation in Locally Advanced Head and Neck Squamous Cell Carcinoma
NCT01695122
Instituto do Cancer do Estado de São PauloPhase 2
CompletedImmunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Human Papillomavirus-Associate
NCT01585428
National Cancer Institute (NCI)Phase 2
UnknownSafety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx
NCT01516996
The Second People's Hospital of SichuanPhase 2
CompletedA Phase II Study In Patients With Advanced Head And Neck Cancer Of Standard Chemoradiation And Add-On Cetuxima
NCT01435252
University of ZurichPhase 2
CompletedRespiratory-Swallow Training in Veterans With Oropharyngeal Cancer
NCT01032928
US Department of Veterans AffairsPhase 2
CompletedRole of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
NCT01358097
Icahn School of Medicine at Mount Sinai
WithdrawnConcordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract
NCT01175499
University of California, San FranciscoN/A
CompletedEffectiveness of Adjuvant Radiotherapy in Small Oropharyngeal Squamous Cell Cancer and Single Lymph Node Metas
NCT00964977
Johannes Gutenberg University MainzPhase 3
CompletedHuman Papillomavirus (HPV) Oral Transmission Study in Partners Over Time
NCT01342978
Johns Hopkins Bloomberg School of Public Health
CompletedPhysiotherapy Treatment for Patients Suffering From Head and Neck Cancer
NCT00780312
Rigshospitalet, DenmarkPhase 2
UnknownSexual Behavior in Head and Neck Cancer Patients
NCT00662662
M.D. Anderson Cancer Center
CompletedNicotine Levels With Response Rates to Radiation Alone or With Chemo In Head & Neck Cancer
NCT01084733
Mahesh Kudrimoti
CompletedA Pilot Trial of Image-Guided Adaptive Radiotherapy for Head and Neck Cancer
NCT00490282
M.D. Anderson Cancer CenterN/A
CompletedRobotic Assisted Surgery in Upper Aerodigestive Tract Surgery
NCT00473564
University of Alabama at BirminghamN/A
CompletedSexual Behavior in Oropharyngeal Patients Versus Head and Neck Cancer Patients, With or Without HPV Infection
NCT00508170
M.D. Anderson Cancer Center
Active Not RecruitingDepression and Adherence in Head and Neck Cancer
NCT00498875
M.D. Anderson Cancer Center
CompletedGene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx
NCT00064103
National Cancer Institute (NCI)Phase 1 / Phase 2
WithdrawnONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer
NCT00006106
National Cancer Institute (NCI)Phase 1
CompletedBowman-Birk Inhibitor Concentrate in Preventing Cancer in Patients With Oral Leukoplakia
NCT00330382
National Cancer Institute (NCI)Phase 2